Cargando…
The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)
Among several peroxisomal neurodegenerative disorders, the pseudoneonatal adrenoleukodystrophy (P-NALD) is characterized by the acyl-coenzyme A oxidase 1 (ACOX1) deficiency, which leads to the accumulation of very-long-chain fatty acids (VLCFA) and inflammatory demyelination. However, the components...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791418/ https://www.ncbi.nlm.nih.gov/pubmed/22508517 http://dx.doi.org/10.1210/en.2012-1137 |
_version_ | 1782286717949050880 |
---|---|
author | El Hajj, H. I. Vluggens, A. Andreoletti, P. Ragot, K. Mandard, S. Kersten, S. Waterham, H. R. Lizard, G. Wanders, R. J. A. Reddy, J. K. Cherkaoui-Malki, Mustapha |
author_facet | El Hajj, H. I. Vluggens, A. Andreoletti, P. Ragot, K. Mandard, S. Kersten, S. Waterham, H. R. Lizard, G. Wanders, R. J. A. Reddy, J. K. Cherkaoui-Malki, Mustapha |
author_sort | El Hajj, H. I. |
collection | PubMed |
description | Among several peroxisomal neurodegenerative disorders, the pseudoneonatal adrenoleukodystrophy (P-NALD) is characterized by the acyl-coenzyme A oxidase 1 (ACOX1) deficiency, which leads to the accumulation of very-long-chain fatty acids (VLCFA) and inflammatory demyelination. However, the components of this inflammatory process in P-NALD remain elusive. In this study, we used transcriptomic profiling and PCR array analyses to explore inflammatory gene expression in patient fibroblasts. Our results show the activation of IL-1 inflammatory pathway accompanied by the increased secretion of two IL-1 target genes, IL-6 and IL-8 cytokines. Human fibroblasts exposed to very-long-chain fatty acids exhibited increased mRNA expression of IL-1α and IL-1β cytokines. Furthermore, expression of IL-6 and IL-8 cytokines in patient fibroblasts was down-regulated by MAPK, p38MAPK, and Jun N-terminal kinase inhibitors. Thus, the absence of acyl-coenzyme A oxidase 1 activity in P-NALD fibroblasts triggers an inflammatory process, in which the IL-1 pathway seems to be central. The use of specific kinase inhibitors may permit the modulation of the enhanced inflammatory status. |
format | Online Article Text |
id | pubmed-3791418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-37914182013-11-01 The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) El Hajj, H. I. Vluggens, A. Andreoletti, P. Ragot, K. Mandard, S. Kersten, S. Waterham, H. R. Lizard, G. Wanders, R. J. A. Reddy, J. K. Cherkaoui-Malki, Mustapha Endocrinology Brief Reports Among several peroxisomal neurodegenerative disorders, the pseudoneonatal adrenoleukodystrophy (P-NALD) is characterized by the acyl-coenzyme A oxidase 1 (ACOX1) deficiency, which leads to the accumulation of very-long-chain fatty acids (VLCFA) and inflammatory demyelination. However, the components of this inflammatory process in P-NALD remain elusive. In this study, we used transcriptomic profiling and PCR array analyses to explore inflammatory gene expression in patient fibroblasts. Our results show the activation of IL-1 inflammatory pathway accompanied by the increased secretion of two IL-1 target genes, IL-6 and IL-8 cytokines. Human fibroblasts exposed to very-long-chain fatty acids exhibited increased mRNA expression of IL-1α and IL-1β cytokines. Furthermore, expression of IL-6 and IL-8 cytokines in patient fibroblasts was down-regulated by MAPK, p38MAPK, and Jun N-terminal kinase inhibitors. Thus, the absence of acyl-coenzyme A oxidase 1 activity in P-NALD fibroblasts triggers an inflammatory process, in which the IL-1 pathway seems to be central. The use of specific kinase inhibitors may permit the modulation of the enhanced inflammatory status. Endocrine Society 2012-06 2012-04-16 /pmc/articles/PMC3791418/ /pubmed/22508517 http://dx.doi.org/10.1210/en.2012-1137 Text en Copyright © 2012 by The Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/us/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Reports El Hajj, H. I. Vluggens, A. Andreoletti, P. Ragot, K. Mandard, S. Kersten, S. Waterham, H. R. Lizard, G. Wanders, R. J. A. Reddy, J. K. Cherkaoui-Malki, Mustapha The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) |
title | The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) |
title_full | The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) |
title_fullStr | The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) |
title_full_unstemmed | The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) |
title_short | The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) |
title_sort | inflammatory response in acyl-coa oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy) |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791418/ https://www.ncbi.nlm.nih.gov/pubmed/22508517 http://dx.doi.org/10.1210/en.2012-1137 |
work_keys_str_mv | AT elhajjhi theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT vluggensa theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT andreolettip theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT ragotk theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT mandards theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT kerstens theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT waterhamhr theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT lizardg theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT wandersrja theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT reddyjk theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT cherkaouimalkimustapha theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT elhajjhi inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT vluggensa inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT andreolettip inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT ragotk inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT mandards inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT kerstens inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT waterhamhr inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT lizardg inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT wandersrja inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT reddyjk inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy AT cherkaouimalkimustapha inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy |